References
- Stenson KM, MacCracken E, Kunnavakkam R, Cohen W, Ezra E, Portugal LD, et al. Chemoradiation for patients with large-volume laryngeal cancers. Head Neck 2012;34:1162–7.
- Ancona C, Badaloni C, Mataloni F, Bolignano A, Bucci S, Cesaroni G, et al. Mortality and morbidity in a population exposed to multiple sources of air pollution: a retrospective cohort study using air dispersion models. Environ Res 2015;137:467–74.
- Varghese B, Babu S, Desai K, Bava A, George P, Iype E, et al. Prospective study of outcomes of surgically treated larynx and hypopharyngeal cancers. Indian J Cancer 2014;51:104.
- Shang X, Pan H, Li M, Miao X, Ding H. Lonicera japonica Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol 2011;138:1–21.
- Garavello W, Randi G, Bosetti C, Dal Maso L, Negri E, Barzan L, et al. Body size and laryngeal cancer risk. Ann Oncol 2006;17:1459–63.
- Epistaxis I. JAMA Otolaryngology – head & neck surgery. JAMA 2014;140:789–892.
- Yeasmeen T, Parvin R, Khan MAH. Tobacco: the silent killer. J Enam Med Coll 2014;4:72–4.
- Gu J, Han T, Ma R-H, Zhu Y-L, Jia Y-N, Du J-J, et al. SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer. Int J Oncol 2014;44:481–90.
- Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 2013;31:845–52.
- Lescaille G, Menashi S, Cavelier-Balloy B, Khayati F, Quemener C, Podgorniak MP, et al. EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression. BMC Cancer 2012;12:115.
- Ahmed RA, Shawky AEL-A, Hamed RH. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma. Pathol Oncol Res 2014;20:625–33.
- Zvrko E, Mikić A, Jančić S. Relationship of E-cadherin with cervical lymph node metastasis in laryngeal cancer. Collegium Antropologicum 2013;36:119–24.
- Pan Y, Shan W, Fang H, Guo M, Nie Z, Huang Y, et al. Sensitive and visible detection of apoptotic cells on Annexin-V modified substrate using aminophenylboronic acid modified gold nanoparticles (APBA-GNPs) labeling. Biosens Bioelectron 2014;52:62–8.
- Johnson JT, Myers EN. Cervical lymph node disease in laryngeal cancer. Laryngeal cancer. New York: Thieme Medical Publishers; 1991. pp 22–6.
- Loddo M, Kingsbury S, Rashid M, Proctor I, Holt C, Young J, et al. Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. Br J Cancer 2009;100:959–70.
- Paksoy M, Hardal U, Caglar C. Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement. J Cancer Res Clin Oncol 2011;137:1371–7.
- Baranwal S, Alahari SK. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun 2009;384:6–11.
- Wong AS, Gumbiner BM. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 2003;161:1191–203.
- Moersig W, Horn S, Hilker M, Mayer E, Oelert H. Transfection of E-cadherin cDNA in human lung tumor cells reduces invasive potential of tumors. Thorac Cardiovasc Surg 2002;50:45–8.
- Nijkamp MM, Span PN, Hoogsteen IJ, van der Kogel AJ, Kaanders JH, Bussink J. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol 2011;99:344–8.